Advent International has agreed to sell Czech generic drugmaker Zentiva to Chicago-based private equity firm GTCR in a €4.1bn deal, marking one of Europe’s largest healthcare transactions this year, according to a report by the Financial Times. To a Report by private equity wire. 11.09.2025
